shionogi
The Quantitative Systems Pharmacology (QSP) Lead will establish and operationalize QSP modeling to support rare disease development decisions, overseeing end‑to‑end model creation, external partner management, and integration of quantitative insights into clinical strategy. The role collaborates across Clinical Development, Pharmacology, Biostatistics, Translational, and Regulatory functions to deliver decision‑grade analysis packages.
Headquarters
Florham Park, New Jersey, United States
Company Size
501-1000 employees
Founded
2001
Shionogi Inc. is a discovery-based pharmaceutical company dedicated to developing, partnering, and commercializing medicines to address serious unmet medical needs. It advances a diverse pipeline through internal R&D, clinical trials, and collaborations, including programs for rare diseases (e.g., Fragile X syndrome) and other therapeutic areas. The company emphasizes transparency, sustainability, patient advocacy, and support for investigators through grants and expanded-access policies. Leveraging global resources and partnerships, Shionogi works to bring novel therapies to patients and healthcare stakeholders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for shionogi.
48% above the average for this role
Associate Director - QSP Quantitative Systems Pharmacology
sanofi us
Senior Director, Quantitative Systems Pharmacology (QSP)
Merck & Co., Inc.
Scientist, Quantitative Systems Pharmacology
sanofi us
QSP Modeler
Sanofi
Postdoctoral Fellow, Quantitative Systems Pharmacology
Pfizer
Quantitative Systems Pharmacology Modeler - all genders
Sanofi